| Dr Pratik Dilip Shah, DO | |
|
142 S Main St, Danville, VA 24541-2922 | |
| (434) 799-3890 | |
| Not Available |
| Full Name | Dr Pratik Dilip Shah |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 13 Years |
| Location | 142 S Main St, Danville, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144589466 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 0116024036 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Moses H. Cone Memorial Hospital, The | Greensboro, NC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Moses Cone Physician Services, Inc | 4284782210 | 306 |
News Archive
The idea of fighting infections and even cancers by inducing protective immune responses may now be a step closer to clinical practice. Researchers have removed a major obstacle to widespread use of so-called adoptive transfer therapy, in which a patient receives "killer" immune cells targeting a disease agent. Existing technologies can easily provide T cells that will recognize a specific antigen, but it has been challenging to identify individual cells most likely to succeed in fighting the disease - until now.
Fixing or replacing faulty genes has emerged as a key to unlocking cures for numerous devastating diseases. But if the new, engineered genes can't find their way into the patient's genomic sequence, they won't help.
Type 1 diabetes affects 30,000 individuals throughout Germany and is the most common metabolic disease in children and adolescents. To halt the ever-increasing incidence, the young investigator group "Immunological Tolerance in Type 1 Diabetes" at the Institute of Diabetes Research directed by Prof. Dr. Anette-Gabriele Ziegler is exploring new strategies to prevent the onset of the disease.
The lack of new or repurposed drugs to treat patients with severe or critical COVID-19 has been one of the biggest hurdles to reducing mortality rates in the ongoing pandemic caused by SARS-CoV-2. A new study describes the potential for the use of the plant molecule isorhamnetin in the management of this virus.
A new study by the Translational Genomics Research Institute and Northern Arizona University used deep DNA sequencing methods to generate the anthrax genome sequence from the victims of the 1979 anthrax outbreak in Sverdlovsk, Russia, when it was part of the USSR.
› Verified 2 days ago
| Entity Name | Moses Cone Physician Services, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093953127 PECOS PAC ID: 4284782210 Enrollment ID: O20090501000202 |
News Archive
The idea of fighting infections and even cancers by inducing protective immune responses may now be a step closer to clinical practice. Researchers have removed a major obstacle to widespread use of so-called adoptive transfer therapy, in which a patient receives "killer" immune cells targeting a disease agent. Existing technologies can easily provide T cells that will recognize a specific antigen, but it has been challenging to identify individual cells most likely to succeed in fighting the disease - until now.
Fixing or replacing faulty genes has emerged as a key to unlocking cures for numerous devastating diseases. But if the new, engineered genes can't find their way into the patient's genomic sequence, they won't help.
Type 1 diabetes affects 30,000 individuals throughout Germany and is the most common metabolic disease in children and adolescents. To halt the ever-increasing incidence, the young investigator group "Immunological Tolerance in Type 1 Diabetes" at the Institute of Diabetes Research directed by Prof. Dr. Anette-Gabriele Ziegler is exploring new strategies to prevent the onset of the disease.
The lack of new or repurposed drugs to treat patients with severe or critical COVID-19 has been one of the biggest hurdles to reducing mortality rates in the ongoing pandemic caused by SARS-CoV-2. A new study describes the potential for the use of the plant molecule isorhamnetin in the management of this virus.
A new study by the Translational Genomics Research Institute and Northern Arizona University used deep DNA sequencing methods to generate the anthrax genome sequence from the victims of the 1979 anthrax outbreak in Sverdlovsk, Russia, when it was part of the USSR.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Pratik Dilip Shah, DO 1202 Deerfield Dr, Reidsville, NC 27320-8353 Ph: () - | Dr Pratik Dilip Shah, DO 142 S Main St, Danville, VA 24541-2922 Ph: (434) 799-3890 |
News Archive
The idea of fighting infections and even cancers by inducing protective immune responses may now be a step closer to clinical practice. Researchers have removed a major obstacle to widespread use of so-called adoptive transfer therapy, in which a patient receives "killer" immune cells targeting a disease agent. Existing technologies can easily provide T cells that will recognize a specific antigen, but it has been challenging to identify individual cells most likely to succeed in fighting the disease - until now.
Fixing or replacing faulty genes has emerged as a key to unlocking cures for numerous devastating diseases. But if the new, engineered genes can't find their way into the patient's genomic sequence, they won't help.
Type 1 diabetes affects 30,000 individuals throughout Germany and is the most common metabolic disease in children and adolescents. To halt the ever-increasing incidence, the young investigator group "Immunological Tolerance in Type 1 Diabetes" at the Institute of Diabetes Research directed by Prof. Dr. Anette-Gabriele Ziegler is exploring new strategies to prevent the onset of the disease.
The lack of new or repurposed drugs to treat patients with severe or critical COVID-19 has been one of the biggest hurdles to reducing mortality rates in the ongoing pandemic caused by SARS-CoV-2. A new study describes the potential for the use of the plant molecule isorhamnetin in the management of this virus.
A new study by the Translational Genomics Research Institute and Northern Arizona University used deep DNA sequencing methods to generate the anthrax genome sequence from the victims of the 1979 anthrax outbreak in Sverdlovsk, Russia, when it was part of the USSR.
› Verified 2 days ago
Dr. Buddy Buford Stokes Ii, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1955 Memorial Dr, Danville, VA 24541 Phone: 434-799-2055 Fax: 434-799-2044 | |
Dr. Daniel Demetrios Collector, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 109 Bridge St Ste 201, Danville, VA 24541 Phone: 434-799-4488 Fax: 434-773-6977 | |
Dr. Timothy Wayne Brotherton, M,D, Internal Medicine Medicare: Medicare Enrolled Practice Location: 125 Executive Dr, Ste J, Danville, VA 24541 Phone: 434-793-0044 Fax: 434-792-8864 | |
Syed Aftab Ahmed, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 125 Executive Dr, Suite K, Danville, VA 24541 Phone: 434-792-7471 Fax: 434-792-1087 | |
Dr. Stecker Tam Pierson, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 125 Executive Dr Ste H, Danville, VA 24541 Phone: 434-791-1345 Fax: 434-773-6811 | |
Subash Ala, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 142 S Main St, Danville, VA 24541 Phone: 434-799-2225 | |
Sheranda C Gunn-nolan, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 142 S Main St, Danville, VA 24541 Phone: 434-799-3859 Fax: 434-773-6803 |